Last week, Elizabeth Campbell of the #DarstLab received the Emil von Behring Prize from Philipps-Universität for her contribution to elucidating the structure of the SARS-CoV-2 polymerase. Congratulations! 📷 : Christian Stein

Barbara Bosch is in the Clinical Scholars Program in Elizabeth Campbell’s group (#DarstLab), where she studies Mycobacterium tuberculosis (MTB), the world’s deadliest bacterium. How did she come to study TB, and where is her research heading next? #ScientistsofRockefeller

AlphaFold: Research accelerator and hypothesis generator: Molecular Cell cell.com/molecular-cell…

Molecular switching of a DNA-sliding clamp to a repressor mediates long-range gene silencing biorxiv.org/cgi/content/sh… #biorxiv_micrbio

Thrilled to share our latest paper nature ! Here we studied the mechanism of transcription for Mycobacterium tuberculosis, the deadly pathogen that causes TB. This is a fun collaboration with the wonderful Rock Lab 🧬🧫 Darst-Campbell Lab Rockefeller University (1/n) rdcu.be/dzTa7

Early intermediates in bacterial RNA polymerase promoter melting visualized by time-resolved cryo-electron microscopy biorxiv.org/cgi/content/sh… #bioRxiv

This is a great program. Please apply! Rockefeller University

A novel sequencing technique from LiuLab_Rockefeller and Rock Lab 🧬🧫 reveals a genetic trick TB may be using to evade the immune system and resist antibiotics. #RockefellerScience rockefeller.edu/news/35563-tb-…

Check out this nice news piece Rockefeller University on our recent Mtb SEnd-seq paper! Congratulations again to all the co-authors ninjaaaaainny @RubyFroom Darst-Campbell Lab Rock Lab 🧬🧫 🎊🍾🎉

Proud to share our work out now in nature nature.com/articles/s4158…! In an amazing collaboration w/ Liz Campbell & Maddie Delbeau Darst-Campbell Lab we identify the/a source of the fitness cost of rifampicin resistance (RifR) in Mtb and how some compensatory mutations rescue the cost!

If so, check out Kathryn Eckartt and Maddie’s work in nature. This was a wonderful collaboration with Darst-Campbell Lab and LandickLab. Rockefeller University. rdcu.be/dBUjv

Ever wondered how to prioritize drug targets? Barbara's review on target vulnerability may give you some new ideas: doi.org/10.1111/nyas.1…